after reconstitution, low or high level of FT3, FT4, T3, T4, Tup, and Theophylline in human plasma with sodium azide (0.2%), preservatives, and protein stabilizers.

共有 1 個藥物證書使用此成份

申請商
西門子醫療設備股份有限公司 
適應症
含量
發證日期
2005-12-16